Task: Answer the multiple choice question.
Question: Which drug exhibits a 17.349\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any additional words.
Options:
a. CC(=O)Nc1nc(C)c(C(C)=O)s1
b. CCc1nnc(NC(=O)c2cccc(S(=O)(=O)N3CCCC3)c2)s1
c. CCN(C(=O)COC(=O)c1cccn1C)C1CCS(=O)(=O)C1
d. COC(=O)c1cn(C(=O)c2ccco2)c2ccccc12
Answer: b. CCc1nnc(NC(=O)c2cccc(S(=O)(=O)N3CCCC3)c2)s1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCc1nnc(NC(=O)c2cccc(S(=O)(=O)N3CCCC3)c2)s1
CCc1nnc(NC(=O)c2cccc(S(=O)(=O)N3CCCC3)c2)s1
N-(5-ethyl-1,3,4-thiadiazol-2-yl)-3-pyrrolidin-1-ylsulfonylbenzamide